论文部分内容阅读
<正>1文献来源Jnne PA,Shaw AT,Pereira JR,et al.Selumetinib plus Docetaxel for KRAS-mutant advanced non-small-cell lung cancer:A randomised,multicentre,placebo-controlled,phase 2 study[J].Lancet Oncol,2013,14(1):38-47.